McLarnon James G
Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, The University of British Columbia 2176 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3.
Am J Neurodegener Dis. 2012;1(3):199-204. Epub 2012 Nov 18.
The net migration of microglia induced by deposits of amyloid beta (Aβ) constitutes a chemotactic response of resident neuroimmune brain cells. This process serves to localize clusters of microglia nearby Aβ deposits preparatory to cellular activation and functional responses. Microglial responses to Aβ deposits localized in brain parenchyma and in blood vessels lead to acute and chronic neuroinflammation in Alzheimer's disease (AD) brain. This review summarizes studies on the prominent chemotactic factors MCP-1, MIP-1α and IL-8 and also includes recent work indicating VEGF and fractalkine as chemotactic agents. The possibility that microglial release of MCP-1 may play a role in mediating chemotactic responses of neural progenitor cells is also considered. The plethora of chemotactic factors and their cognate receptors suggests the utility in testing pharmacological modulation of chemotaxis for effects to inhibit chronic neuroinflammation and confer neuroprotection in AD animal models.
由β-淀粉样蛋白(Aβ)沉积诱导的小胶质细胞净迁移构成了驻留神经免疫脑细胞的趋化反应。这一过程有助于将小胶质细胞簇定位在Aβ沉积物附近,为细胞激活和功能反应做准备。小胶质细胞对脑实质和血管中Aβ沉积物的反应会导致阿尔茨海默病(AD)大脑中的急性和慢性神经炎症。本综述总结了对主要趋化因子单核细胞趋化蛋白-1(MCP-1)、巨噬细胞炎性蛋白-1α(MIP-1α)和白细胞介素-8(IL-8)的研究,还包括最近表明血管内皮生长因子(VEGF)和 fractalkine 作为趋化剂的工作。小胶质细胞释放的MCP-1可能在介导神经祖细胞趋化反应中发挥作用这一可能性也被考虑在内。大量的趋化因子及其同源受体表明,在AD动物模型中测试趋化性的药理学调节以抑制慢性神经炎症和提供神经保护作用具有实用性。